Rosa Conde
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rosa Conde has a total of 143 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Antonio de Luis
Center of Investigation Endocrinology and Nutrition, Valladolid University Clinical Hospital, Medicine School University, 47002 Valladolid, Spain
87 shared publications Olatz Izaola
Center of Investigation of Endocrinology and Nutrition; Medicine School and Unit of Investigation; Hospital Rio Hortega; University of Valladolid; Valladolid Spain
40 shared publicationsR. Aller
Center of Investigation of Endocrinology and Clinical Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
33 shared publicationsO. Izaola
Center of Investigation of Endocrinology and Clinical Nutrition, Medicine School and Unit of Investigation, Hospital Rio Hortega, University of Valladolid, Valladolid, Spain
30 shared publicationsManuel Gonzalez Sagrado
Center of Investigation of Endocrinology and Nutrition; Medicine School and Unit of Investigation; Hospital Rio Hortega; University of Valladolid; Valladolid Spain
27 shared publicationsRocio Aller
27 shared publications
Latest Publications
- 1 March 2019
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 53 (3) , 191-196
Role of Full-spectrum Endoscopy in Colorectal Cancer Screening
Goals: The aim of this study was to compare a new, full-spectrum endoscope (Fuse; EndoChoice, Alpharetta, GA) to standard forward-viewing colonoscopy in the detection of colorectal neoplasms. Background: Colonoscopy, the gold standard for the detection of colorectal cancer, fails to detect 22% to 28% of polyps, increasing the risk of interval cancer. Endoscopic improvement of the adenoma detection rate decrease interval carcinomas. Full-spectrum endoscopy (FUSE) (330-degree field of view), in a tandem study, has been shown to reduce the adenoma miss rate. Study: Prospective, randomized study of 249 patients in patients referred from the colorectal screening program with a positive fecal occult blood test (FOBT). Patients were randomized to standard forward-viewing colonoscopy (170 degrees) or to full-spectrum colonoscopy with the Fuse system (330 degrees). Study variables were the adenoma detection rate, the polyp detection rate, the mean number of adenomas per procedure, the lesions detected according to the location, morphology and size, cecal intubation rate, total procedure time, insertion time to the cecum, therapeutic success, and adverse events. Results: The Fuse system did not produce a significantly higher adenoma detection rate than standard forward-viewing colonoscopy (FUSE 73.1% vs. standard colonoscopy 68.1%; P=0.47) but did have a significantly longer insertion time (FUSE 6.2 min vs. standard colonoscopy 4.2 min; P< 0.001). Further analysis failed to reveal any significant difference in polyp/adenoma detection rates by lesion size or colonic section. Conclusions: FUSE did not detect significantly more colorectal neoplasia than forward viewing colonoscopy in a medium-risk CRC screening population with positive FOBT.
- 1 March 2019
- Published by Wolters Kluwer Health in Journal of Clinical Gastroenterology
- Vol. 53 (3) , 191-196
Role of Full-spectrum Endoscopy in Colorectal Cancer Screening
Goals: The aim of this study was to compare a new, full-spectrum endoscope (Fuse; EndoChoice, Alpharetta, GA) to standard forward-viewing colonoscopy in the detection of colorectal neoplasms. Background: Colonoscopy, the gold standard for the detection of colorectal cancer, fails to detect 22% to 28% of polyps, increasing the risk of interval cancer. Endoscopic improvement of the adenoma detection rate decrease interval carcinomas. Full-spectrum endoscopy (FUSE) (330-degree field of view), in a tandem study, has been shown to reduce the adenoma miss rate. Study: Prospective, randomized study of 249 patients in patients referred from the colorectal screening program with a positive fecal occult blood test (FOBT). Patients were randomized to standard forward-viewing colonoscopy (170 degrees) or to full-spectrum colonoscopy with the Fuse system (330 degrees). Study variables were the adenoma detection rate, the polyp detection rate, the mean number of adenomas per procedure, the lesions detected according to the location, morphology and size, cecal intubation rate, total procedure time, insertion time to the cecum, therapeutic success, and adverse events. Results: The Fuse system did not produce a significantly higher adenoma detection rate than standard forward-viewing colonoscopy (FUSE 73.1% vs. standard colonoscopy 68.1%; P=0.47) but did have a significantly longer insertion time (FUSE 6.2 min vs. standard colonoscopy 4.2 min; P< 0.001). Further analysis failed to reveal any significant difference in polyp/adenoma detection rates by lesion size or colonic section. Conclusions: FUSE did not detect significantly more colorectal neoplasia than forward viewing colonoscopy in a medium-risk CRC screening population with positive FOBT.
- 1 January 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6 (1) , 201-207
Cocaine Allergy in Drug-Dependent Patients and Allergic People
- 1 January 2018
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 6 (1) , 201-207
Cocaine Allergy in Drug-Dependent Patients and Allergic People
- 17 August 2014
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 29 (6) , 432-436
Effect of Lys656Asn Polymorphism of Leptin Receptor Gene on Cardiovascular Risk Factors and Serum Adipokine Levels after a High Polyunsaturated Fat Diet in Obese Patients
Background: Human obesity is characterized by high levels of leptin, and leptin levels may change with weight loss and dietary restriction. The aim of our study was to investigate the influence of Lys656Asn polymorphism in the leptin receptor gene on cardiovascular risk factors, weight loss, and serum leptin levels to a high polyunsaturated fatty acid (PUFA) hypocaloric diet in obese patients.Design: A sample of 132 obese patients was analyzed in a prospective way with a dietary intervention. The enriched PUFAs hypocaloric intervention consisted in a diet of 1,459 kcal, 45.7% of carbohydrates, 34.4% of lipids, and 19.9% of proteins.Results: In wild‐type group, BMI (−1.9 ± 1.4 kg/m2), weight (−4.4 ± 3.2 kg), fat mass (−4.2 ± 3.8 kg), waist circumference (−4.1 ± 3.1 cm), systolic blood pressure (−7.0 ± 12.1 mmHg), diastolic blood pressure (−3.9 ± 6.8 mmHg), insulin (−1.8 ± 5.6 MUI/l) and HOMA‐IR (−0.5 ± 1.5 Units) decreased. In mutant genotype group, BMI (−2.0 ± 2.1 kg/m2), weight (−3.6 ± 4.1 kg), waist circumference (−3.1 ± 4.1 cm), total cholesterol (−25.2 ± 19.6 mg/dl), LDL cholesterol (−16.6 ± 25.6 mg/dl), and tryglicerides (−26.6 ± 39.1 mg/dl) decreased. Only leptin levels have a significant decrease in wild genotype group (−6.6 ± 10.2 ng/ml) (25.1%).Conclusion: Carriers of ASn656 allele have a different response than wild‐type obese, with a lack of decrease in insulin levels, leptin levels, and HOMA‐IR. However, obese patients with this mutant allele have a better lipid profile after weight loss.
- 17 August 2014
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 29 (6) , 432-436
Effect of Lys656Asn Polymorphism of Leptin Receptor Gene on Cardiovascular Risk Factors and Serum Adipokine Levels after a High Polyunsaturated Fat Diet in Obese Patients
Background: Human obesity is characterized by high levels of leptin, and leptin levels may change with weight loss and dietary restriction. The aim of our study was to investigate the influence of Lys656Asn polymorphism in the leptin receptor gene on cardiovascular risk factors, weight loss, and serum leptin levels to a high polyunsaturated fatty acid (PUFA) hypocaloric diet in obese patients.Design: A sample of 132 obese patients was analyzed in a prospective way with a dietary intervention. The enriched PUFAs hypocaloric intervention consisted in a diet of 1,459 kcal, 45.7% of carbohydrates, 34.4% of lipids, and 19.9% of proteins.Results: In wild‐type group, BMI (−1.9 ± 1.4 kg/m2), weight (−4.4 ± 3.2 kg), fat mass (−4.2 ± 3.8 kg), waist circumference (−4.1 ± 3.1 cm), systolic blood pressure (−7.0 ± 12.1 mmHg), diastolic blood pressure (−3.9 ± 6.8 mmHg), insulin (−1.8 ± 5.6 MUI/l) and HOMA‐IR (−0.5 ± 1.5 Units) decreased. In mutant genotype group, BMI (−2.0 ± 2.1 kg/m2), weight (−3.6 ± 4.1 kg), waist circumference (−3.1 ± 4.1 cm), total cholesterol (−25.2 ± 19.6 mg/dl), LDL cholesterol (−16.6 ± 25.6 mg/dl), and tryglicerides (−26.6 ± 39.1 mg/dl) decreased. Only leptin levels have a significant decrease in wild genotype group (−6.6 ± 10.2 ng/ml) (25.1%).Conclusion: Carriers of ASn656 allele have a different response than wild‐type obese, with a lack of decrease in insulin levels, leptin levels, and HOMA‐IR. However, obese patients with this mutant allele have a better lipid profile after weight loss.
- 28 March 2014
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 29 (2) , 100-105
Relation of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor with Weight, Cardiovascular Risk Factor, and Serum Adipokine Levels in Obese Female Subjects
Studies of the glucagon-like peptide 1 (GLP-1) receptor have been directed at identifying polymorphisms in the GLP-1 receptor gene that may be a contributing factor in the pathogenesis of diabetes mellitus and cardiovascular risk factors. Nevertheless, the role of GLP-1 variants on body weight, cardiovascular risk factors, and adipokines remains unclear in obese patients. Our aim was to analyze the effects of rs6923761 GLP-1 receptor polymorphism on body weight, cardiovascular risk factors, and serum adipokine levels in nondiabetic obese females. A sample of 645 obese nondiabetic Caucasian females was enrolled in a prospective way. Basal fasting glucose, c-reactive protein (CRP), insulin, insulin resistance (homeostasis model assessment (HOMA)), total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides concentration, and adipokines were measured. Weights, body mass index (BMI), waist circumference, fat mass by bioimpedance, and blood pressure measures were measured. Three hundred and twenty-seven participants (50.7%) had the genotype GG and 318 (49.3%) study subjects had the next genotypes; GA (270 study subjects, 41.9%) or AA (48 study subjects, 7.4%) (second group). In wild group (GG genotype), BMI (1.8 ± 2.3 kg/m(2) ; P < 0.05), weight (3.1 ± 1.3 kg; P < 0.05), fat mass (2.4 ± 1.1 kg; P < 0.05), waist circumference (2.7 ± 1.9 cm; P < 0.05), triglyceride levels (10.4 ± 5.3 mg/dl; P < 0.05), interleukin 6 (IL-6) (1.5 ± 0.9 ng/dl; P < 0.05), resistin (1.1 ± 0.3 ng/dl; P < 0.05), and leptin (30.1 ± 10.3 ng/dl; P < 0.05) levels were higher than mutant group (GA + AA). Data from our study revealed an association with decreased metabolic and cardiovascular markers in obese females. BMI weight, fat mass, waist circumference, triglycerides, leptin, resistin, and IL-6 serum levels were lower in subjects with A allele than non-A allele subjects.
- 28 March 2014
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 29 (2) , 100-105
Relation of the rs6923761 Gene Variant in Glucagon-Like Peptide 1 Receptor with Weight, Cardiovascular Risk Factor, and Serum Adipokine Levels in Obese Female Subjects
Studies of the glucagon-like peptide 1 (GLP-1) receptor have been directed at identifying polymorphisms in the GLP-1 receptor gene that may be a contributing factor in the pathogenesis of diabetes mellitus and cardiovascular risk factors. Nevertheless, the role of GLP-1 variants on body weight, cardiovascular risk factors, and adipokines remains unclear in obese patients. Our aim was to analyze the effects of rs6923761 GLP-1 receptor polymorphism on body weight, cardiovascular risk factors, and serum adipokine levels in nondiabetic obese females. A sample of 645 obese nondiabetic Caucasian females was enrolled in a prospective way. Basal fasting glucose, c-reactive protein (CRP), insulin, insulin resistance (homeostasis model assessment (HOMA)), total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides concentration, and adipokines were measured. Weights, body mass index (BMI), waist circumference, fat mass by bioimpedance, and blood pressure measures were measured. Three hundred and twenty-seven participants (50.7%) had the genotype GG and 318 (49.3%) study subjects had the next genotypes; GA (270 study subjects, 41.9%) or AA (48 study subjects, 7.4%) (second group). In wild group (GG genotype), BMI (1.8 ± 2.3 kg/m(2) ; P < 0.05), weight (3.1 ± 1.3 kg; P < 0.05), fat mass (2.4 ± 1.1 kg; P < 0.05), waist circumference (2.7 ± 1.9 cm; P < 0.05), triglyceride levels (10.4 ± 5.3 mg/dl; P < 0.05), interleukin 6 (IL-6) (1.5 ± 0.9 ng/dl; P < 0.05), resistin (1.1 ± 0.3 ng/dl; P < 0.05), and leptin (30.1 ± 10.3 ng/dl; P < 0.05) levels were higher than mutant group (GA + AA). Data from our study revealed an association with decreased metabolic and cardiovascular markers in obese females. BMI weight, fat mass, waist circumference, triglycerides, leptin, resistin, and IL-6 serum levels were lower in subjects with A allele than non-A allele subjects.
- 7 December 2013
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 63 (4) , 277-282
Evaluation of Weight Loss and Adipocytokine Levels after Two Hypocaloric Diets with Different Macronutrient Distribution in Obese Subjects with the rs6923761 Gene Variant of Glucagon-Like Peptide 1 Receptor
Background: The role of glucagon-like peptide-1 receptor (GLP-1R) variants on body weight response after dietary intervention has not been evaluated so far. Objective: Our aim was to evaluate weight loss and adipocytokine levels after two hypocaloric diets with different macronutrient distribution in obese subjects with rs6923761. Design: A sample of 280 obese subjects was randomized to two hypocaloric diets. Results: 124 patients (44.3%) had the genotype GG (wild-type) and 156 (55.7%) had another genotype (mutant), i.e. GA (n = 132, 47.1%) or AA (n = 24, 8.6%). With the type I diet (low in carbohydrates) in the wild-type and mutant groups, BMI, weight, fat mass, waist circumference, insulin levels, insulin resistance and triglycerides decreased. Anthropometric parameters were higher in non-A-allele carriers than A-allele carriers. With the type II diet (low in fats) in all genotypes, BMI, weight, fat mass, waist circumference, insulin levels, total cholesterol and LDL cholesterol decreased. Conclusion: Our data showed better anthropometric parameters in obese subjects with the mutant allele (A) of the rs6923761 GLP-1R polymorphism. A lack of association of this polymorphism with weight loss or biochemical parameters after two different hypocaloric diets was observed.
- 7 December 2013
- Published by S. Karger AG in Annals of Nutrition and Metabolism
- Vol. 63 (4) , 277-282
Evaluation of Weight Loss and Adipocytokine Levels after Two Hypocaloric Diets with Different Macronutrient Distribution in Obese Subjects with the rs6923761 Gene Variant of Glucagon-Like Peptide 1 Receptor
Background: The role of glucagon-like peptide-1 receptor (GLP-1R) variants on body weight response after dietary intervention has not been evaluated so far. Objective: Our aim was to evaluate weight loss and adipocytokine levels after two hypocaloric diets with different macronutrient distribution in obese subjects with rs6923761. Design: A sample of 280 obese subjects was randomized to two hypocaloric diets. Results: 124 patients (44.3%) had the genotype GG (wild-type) and 156 (55.7%) had another genotype (mutant), i.e. GA (n = 132, 47.1%) or AA (n = 24, 8.6%). With the type I diet (low in carbohydrates) in the wild-type and mutant groups, BMI, weight, fat mass, waist circumference, insulin levels, insulin resistance and triglycerides decreased. Anthropometric parameters were higher in non-A-allele carriers than A-allele carriers. With the type II diet (low in fats) in all genotypes, BMI, weight, fat mass, waist circumference, insulin levels, total cholesterol and LDL cholesterol decreased. Conclusion: Our data showed better anthropometric parameters in obese subjects with the mutant allele (A) of the rs6923761 GLP-1R polymorphism. A lack of association of this polymorphism with weight loss or biochemical parameters after two different hypocaloric diets was observed.
- 1 September 2013
- Published by Elsevier in Medicina Clinica
- Vol. 141 (5) , 189-193
Role of G308 promoter variant of tumor necrosis factor alpha gene on weight loss and metabolic parameters after a high monounsaturated versus a high polyunsaturated fat hypocaloric diets
- 1 September 2013
- Published by Elsevier in Medicina Clinica
- Vol. 141 (5) , 189-193
Role of G308 promoter variant of tumor necrosis factor alpha gene on weight loss and metabolic parameters after a high monounsaturated versus a high polyunsaturated fat hypocaloric diets
- 1 August 2013
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 24 (8) , 1431-1435
Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and their influence on anthropometric parameters and metabolic parameters under a high monounsaturated vs. high polyunsaturated fat hypocaloric diets
- 1 August 2013
- Published by Elsevier in The Journal of Nutritional Biochemistry
- Vol. 24 (8) , 1431-1435
Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and their influence on anthropometric parameters and metabolic parameters under a high monounsaturated vs. high polyunsaturated fat hypocaloric diets
- 1 July 2013
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 27 (4) , 346-350
Relation of the rs9939609 gene variant in FTO with metabolic syndrome in obese female patients
- 1 July 2013
- Published by Elsevier in Journal of Diabetes and its Complications
- Vol. 27 (4) , 346-350
Relation of the rs9939609 gene variant in FTO with metabolic syndrome in obese female patients